Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Annals of the American Thoracic Society|December 16, 2020
Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease: A 12-Month Open-Label Extension Clinical TrialKevin L Winthrop, Patrick A Flume, Rachel Thomson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 26, 2022
α1-Antitrypsin Binds to the Glucocorticoid Receptor with Anti-Inflammatory and Antimycobacterial Significance in MacrophagesXiyuan Bai, An Bai, Michele Tomasicchio, et al.
Chest|April 22, 2021
Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term ExposureDavid E Griffith, Rachel Thomson, Patrick A Flume, et al.
MMWR. Morbidity and Mortality Weekly Report|May 9, 2024
Notes from the Field: Potential Outbreak of Extrapulmonary Mycobacterium abscessus subspecies massiliense Infections from Stem Cell Treatment Clinics in Mexico - Arizona and Colorado, 2022Minh-Vu H Nguyen, Nabeeh A Hasan, Vinicius Calado Nogueira De Moura, et al.
Annals of the American Thoracic Society|March 31, 2026
Amikacin liposome inhalation suspension in newly diagnosed Mycobacterium avium complex lung disease (ARISE): a 6-month double-blind, active comparator trialCharles L Daley, Jakko van Ingen, James D Chalmers, et al.
International Journal of Systematic and Evolutionary Microbiology|August 9, 2016
Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus and Mycobacteriumabscessus subsp. bolletii and designation of Mycobacteriumabscessus subsp. massiliense comb. novEnrico Tortoli, Thomas A Kohl, Barbara A Brown-Elliott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 16, 2020
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice GuidelineCharles L Daley, Jonathan M Iaccarino, Christoph Lange, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 7, 2020
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice GuidelineCharles L Daley, Jonathan M Iaccarino, Christoph Lange, et al.
The European Respiratory Journal|July 9, 2020
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guidelineCharles L Daley, Jonathan M Iaccarino, Christoph Lange, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|April 12, 2019
The Clinical Features of Bronchiectasis Associated with Alpha-1 Antitrypsin Deficiency, Common Variable Immunodeficiency and Primary Ciliary Dyskinesia--Results from the U.S. Bronchiectasis Research RegistryEdward Eden, Radmila Choate, Alan Barker, et al.
Pageof 13